BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/18/2019 5:48:09 AM | Browse: 775 | Download: 1315
 |
Received |
|
2019-01-24 01:46 |
 |
Peer-Review Started |
|
2019-01-24 07:18 |
 |
To Make the First Decision |
|
2019-02-26 07:52 |
 |
Return for Revision |
|
2019-02-26 09:00 |
 |
Revised |
|
2019-03-20 14:48 |
 |
Second Decision |
|
2019-03-22 08:19 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2019-03-25 04:43 |
 |
Articles in Press |
|
2019-03-25 04:43 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2019-04-01 13:44 |
 |
Typeset the Manuscript |
|
2019-04-17 00:55 |
 |
Publish the Manuscript Online |
|
2019-04-18 05:48 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Basic Study |
Article Title |
Predictive and prognostic implications of the autophagy-related proteins 4E-binding protein 1, Beclin-1 and microtubule-associated protein 1A/B-light chain 3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Gui-Fang Guo, Yi-Xing Wang, Yi-Jun Zhang, Xiu-Xing Chen, Jia-Bin Lu, Hao-Hua Wang, Chang Jiang, Hui-Quan Qiu and Liang-Ping Xia |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Gui-Fang Guo, MD, PhD, Professor, VIP Department, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou 510000, Guangdong Province, China. guogf@sysucc.org.cn |
Key Words |
4E-binding protein 1; Beclin-1; Microtubule-associated protein 1A/B-light chain 3; Advanced colorectal cancer; Cetuximab efficacy; Prognosis |
Core Tip |
Considering the response rate of cetuximab in advanced colorectal cancer patients with wild-type KRAS, autophagy might be a novel predictor to exclude patients who will not respond to cetuximab. Accordingly, Beclin1, microtubule-associated protein 1A/B-light chain 3 (LC3) and 4E-binding protein 1 (4E-BP1) were studied in this research. We found LC3 is overexpressed in tumor tissues, and the expression levels of Beclin1 and 4E-BP1 were related to overall survival. |
Publish Date |
2019-04-18 05:48 |
Citation |
Guo GF, Wang YX, Zhang YJ, Chen XX, Lu JB, Wang HH, Jiang C, Qiu HJ, Xia LP. Predictive and prognostic implications of the autophagy-related proteins 4E-binding protein 1, Beclin-1 and microtubule-associated protein 1A/B-light chain 3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data. World J Gastroenterol 2019; 25(15): 1840-1853 |
URL |
https://www.wjgnet.com/1007-9327/full/v25/i15/1840.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v25.i15.1840 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345